Company / Income Tax
Amgen Income Tax History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Income Tax
$1.3B
FY2025
5-year range
$519.0M / $1.3B
FY2021-FY2025
Trend
+143.7%
vs FY2024
Sector context
#7 of 202
Health Care
What the data says
Among 202 Health Care companies, Amgen is in the bottom 3% for income tax. Income Tax has fluctuated over the past 10 years, ranging from $519M in FY2024 to $7.6B in FY2017.
Based on SEC 10-K filings.
$1.3B in FY2025 with a 5-year CAGR of +7.8%. Top quartile in the Health Care sector.
Increased from $1.1B to $1.3B over the past 2 years.
Health Care sector context is included.
Income Tax over time
Growth rates
- 3-Year CAGR
- +16.8%
- 5-Year CAGR
- +7.8%
- 10-Year CAGR
- -
Sector benchmark
Bottom 3% in Health CareTop 97% of 202This company $1.3B Sector average $119.7M
▼
+956.4% above sector average
Key checks
Key Insights
- 5-year CAGR of +7.8%, indicating consistent growth.
- In FY2025, income tax increased 143.7% year-over-year.
- Ranks #7 out of 202 companies in the Health Care sector.
- Peak income tax was recorded in FY2017.
Company context
Key Data Points
- Altman Z-Score 0.55 (distress zone, below 1.8 threshold)
- Strong return on equity: 72.8%
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Income TaxValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $1.3B | +143.7% |
| FY2024 | $519.0M | -54.4% |
| FY2023 | $1.1B | +43.3% |
| FY2022 | $794.0M | -1.7% |
| FY2021 | $808.0M | -7.0% |
| FY2020 | $869.0M | -32.9% |
| FY2019 | $1.3B | +12.6% |
| FY2018 | $1.2B | -84.9% |
| FY2017 | $7.6B | +428.7% |
| FY2016 | $1.4B | +38.7% |
As of FY2025 · SEC Form 10-K · Last checked Jun 21, 2026